News Focus
News Focus
Followers 64
Posts 7757
Boards Moderated 1
Alias Born 01/02/2003

Re: Whalatane post# 117026

Saturday, 10/28/2017 4:07:01 PM

Saturday, October 28, 2017 4:07:01 PM

Post# of 447644
KIWI:........"My own view is that Amarin will be like a "dead man walking ", if the ITC does not proceed"


The monthly and quarterly scripts are IMO of minimal importance between now and the report on R-IT.......and the ITC decision is of moderate but not crucial significance.
_________________________________________________________________________


"So if the ITC does not block Dietary supplement versions of Vascepa and R-IT comes in around 12-15% RRR ( my guess ) ...don't expect low co pays from Insurance Co's."


My guess is an RRR of over 30%.......
IMO the main threat to AMARIN investors is that they sell too early, before the denouement with R-IT. I find the differing opinions on this board helpful in staying the course.........I have made many mistakes in my investing career, but the biggest ones were in being shaken out too early and not staying the course.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News